Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Jul-23 9:00 AM View:  | Gillis Steven Director | Vbi Vaccines Inc/bc (VBIV) | 10-Jul-23 | Private Purchase | 609,090 | $1.65 | $1,005,000.00 | 139% 437.02K to 1.05M | |
| 06-Apr-23 5:51 PM View: | Perceptive Advisors LLC 10% Owner | Vbi Vaccines Inc/bc (VBIV) | 06-Apr-23 | Sale | 4,251,560 | $0.11 | $467,672.00 | (9%) 45.69M to 41.44M | |
| 06-Apr-23 5:51 PM View: | Perceptive Advisors LLC 10% Owner | Vbi Vaccines Inc/bc (VBIV) | 05-Apr-23 | Sale | 1,832,560 | $0.13 | $238,233.00 | (4%) 47.52M to 45.69M | |
| 06-Apr-23 5:51 PM View: | Perceptive Advisors LLC 10% Owner | Vbi Vaccines Inc/bc (VBIV) | 04-Apr-23 | Sale | 4,810,620 | $0.16 | $769,700.00 | (9%) 52.34M to 47.52M | |
| 06-Dec-21 10:06 AM View: | Beattie Nell Chief Business Officer | Vbi Vaccines Inc/bc (VBIV) | 03-Dec-21 | Market Purchase | 8,200 | $2.45 | $20,083.40 | 14% 60.0K to 68.2K | (2%) |
| 03-Dec-21 6:22 PM View: | Perceptive Advisors LLC 10% Owner | Vbi Vaccines Inc/bc (VBIV) | 01-Dec-21 | Market Sale | 2,707,460 | $3.31 | $8,961,700.00 | (5%) 55.04M to 52.34M | 18% |
| 30-Jun-21 4:40 PM View: | Perceptive Advisors LLC 10% Owner | Vbi Vaccines Inc/bc (VBIV) | 29-Jun-21 | Market Sale | 646,257 | $3.80 | $2,455,780.00 | (1%) 55.69M to 55.04M | 2% |
| 11-Jun-21 6:41 PM View: | Perceptive Advisors LLC 10% Owner | Vbi Vaccines Inc/bc (VBIV) | 09-Jun-21 | Market Sale | 1,422,570 | $4.00 | $5,690,270.00 | (2%) 57.11M to 55.69M | |
| 11-Jun-21 6:41 PM View: | Perceptive Advisors LLC 10% Owner | Vbi Vaccines Inc/bc (VBIV) | 09-Jun-21 | Exercise (in-the money or at-the-money) | 2,068,820 | $2.75 | $5,689,270.00 | 4% 55.04M to 57.11M | |
| 28-Apr-20 9:00 AM View: | Perceptive Advisors LLC 10% Owner | Vbi Vaccines Inc/bc (VBIV) | 24-Apr-20 | Market Purchase | 9,090,910 | $1.10 | $10,000,000.00 | 20% 45.95M to 55.04M | 182% |
| 07-Oct-19 11:35 AM View: | Diaz-Mitoma Francisco Chief Medical Officer | Vbi Vaccines Inc/bc (VBIV) | 04-Oct-19 | Market Purchase | 40,000 | $0.50 | $20,000.00 | 11% 380.24K to 420.24K | 542% |
| 01-Oct-19 12:39 PM View: | Beattie Nell Chief Business Officer | Vbi Vaccines Inc/bc (VBIV) | 01-Oct-19 | Market Purchase | 10,000 | $0.48 | $4,822.00 | 20% 50.0K to 60.0K | 562% |
| 01-Oct-19 12:39 PM View: | McNulty Christopher CFO and Head of BD Director | Vbi Vaccines Inc/bc (VBIV) | 01-Oct-19 | Market Purchase | 12,000 | $0.47 | $5,676.00 | 48% 25.0K to 37.0K | 575% |
| 07-Oct-19 11:35 AM View: | Diaz-Mitoma Francisco Chief Medical Officer | Vbi Vaccines Inc/bc (VBIV) | 30-Sep-19 | Market Purchase | 14,500 | $0.50 | $7,250.00 | 4% 365.74K to 380.24K | 533% |
| 30-Sep-19 4:22 PM View: | Baxter Jeff CEO, President Director | Vbi Vaccines Inc/bc (VBIV) | 30-Sep-19 | Market Purchase | 150,000 | $0.50 | $75,450.00 | 33% 458.25K to 608.25K | 530% |
| 24-Sep-19 6:30 PM View: | Perceptive Advisors LLC 10% Owner | Vbi Vaccines Inc/bc (VBIV) | 23-Sep-19 | Market Purchase | 20,000,000 | $0.50 | $10,000,000.00 | 77% 25.95M to 45.95M | 526% |
| 01-Jul-19 6:10 AM View: | Diaz-Mitoma Francisco Chief Medical Officer | Vbi Vaccines Inc/bc (VBIV) | 27-Jun-19 | Market Purchase | 8,000 | $1.07 | $8,560.00 | 2% 357.74K to 365.74K | 182% |
| 20-Jun-19 3:59 PM View: | Diaz-Mitoma Francisco Chief Medical Officer | Vbi Vaccines Inc/bc (VBIV) | 20-Jun-19 | Market Purchase | 52,000 | $0.87 | $45,180.00 | 17% 305.74K to 357.74K | 246% |
| 19-Jun-19 12:17 PM View: | Baxter Jeff CEO, President Director | Vbi Vaccines Inc/bc (VBIV) | 19-Jun-19 | Market Purchase | 144,000 | $0.73 | $105,336.00 | 46% 314.25K to 458.25K | 312% |
| 19-Jun-19 12:20 PM View: | Beattie Nell Chief Business Officer | Vbi Vaccines Inc/bc (VBIV) | 19-Jun-19 | Market Purchase | 8,000 | $0.74 | $5,885.60 | 19% 42.0K to 50.0K | 310% |
| 20-Jun-19 10:19 AM View: | Perceptive Advisors LLC 10% Owner | Vbi Vaccines Inc/bc (VBIV) | 18-Jun-19 | Market Purchase | 1,000,000 | $0.65 | $650,000.00 | 4% 24.95M to 25.95M | 363% |
| 18-Jun-19 11:10 AM View: | Perceptive Advisors LLC 10% Owner | Vbi Vaccines Inc/bc (VBIV) | 17-Jun-19 | Market Purchase | 1,000,000 | $0.62 | $618,000.00 | 4% 23.95M to 24.95M | 387% |
| 18-Jun-19 4:08 PM View: | Beattie Nell Chief Business Officer | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-19 | Option Exercise | 6,250 | -- | -- | 17% 35.75K to 42.0K | |
| 18-Jun-19 4:14 PM View: | Baxter Jeff CEO, President Director | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-19 | Option Exercise | 31,250 | -- | -- | 11% 283.0K to 314.25K | |
| 18-Jun-19 4:11 PM View: | Gillis Steven Director | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-19 | Option Exercise | 18,750 | -- | -- | < 1% 3.09M to 3.11M | |
| 18-Jun-19 4:09 PM View: | Dewilde Michel Director | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-19 | Option Exercise | 12,500 | -- | -- | 33% 37.5K to 50.0K | |
| 18-Jun-19 4:10 PM View: | Anderson David Evander Chief Scientific Officer | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-19 | Option Exercise | 21,875 | -- | -- | 17% 126.33K to 148.21K | |
| 04-Feb-19 5:17 PM View: | Baxter Jeff CEO, President Director | Vbi Vaccines Inc/bc (VBIV) | 31-Jan-19 | Grant | 50,000 | -- | -- | 21% 233.0K to 283.0K | |
| 04-Feb-19 5:12 PM View: | Mazaltov Avi Head Global MFG&GM-SciVac Ltd. | Vbi Vaccines Inc/bc (VBIV) | 31-Jan-19 | Grant | 90,000 | -- | -- | 85% 106.0K to 196.0K | |
| 04-Feb-19 5:08 PM View: | Beattie Nell Chief Business Officer | Vbi Vaccines Inc/bc (VBIV) | 31-Jan-19 | Grant | 15,000 | -- | -- | 72% 20.75K to 35.75K | |
| 04-Feb-19 5:13 PM View: | McNulty Christopher CFO and Head of BD | Vbi Vaccines Inc/bc (VBIV) | 31-Jan-19 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 04-Feb-19 5:11 PM View: | Anderson David Evander Chief Scientific Officer | Vbi Vaccines Inc/bc (VBIV) | 31-Jan-19 | Grant | 25,000 | -- | -- | 25% 101.33K to 126.33K | |
| 18-Dec-18 12:10 PM View: | Kariv Tomer Director | Vbi Vaccines Inc/bc (VBIV) | 17-Dec-18 | Market Purchase | 1,428,570 | $1.40 | $2,000,000.00 | 62% 2.3M to 3.72M | 115% |
| 17-Dec-18 9:02 AM View: | Perceptive Advisors LLC 10% Owner | Vbi Vaccines Inc/bc (VBIV) | 13-Dec-18 | Market Purchase | 14,285,700 | $1.40 | $20,000,000.00 | 153% 9.35M to 23.63M | 115% |
| 07-Aug-18 8:38 PM View: | Baxter Jeff CEO, President Director | Vbi Vaccines Inc/bc (VBIV) | 06-Aug-18 | Market Purchase | 8,100 | $1.93 | $15,607.10 | 4% 224.91K to 233.0K | 56% |
| 03-Aug-18 3:21 PM View: | Beattie Nell Chief Business Officer | Vbi Vaccines Inc/bc (VBIV) | 03-Aug-18 | Market Purchase | 2,000 | $2.01 | $4,011.40 | 11% 18.75K to 20.75K | 50% |
| 06-Aug-18 2:37 PM View: | Diaz-Mitoma Francisco Chief Medical Officer | Vbi Vaccines Inc/bc (VBIV) | 03-Aug-18 | Market Purchase | 6,000 | $2.10 | $12,600.00 | 2% 299.74K to 305.74K | 43% |
| 06-Aug-18 11:06 AM View: | Baxter Jeff CEO, President Director | Vbi Vaccines Inc/bc (VBIV) | 03-Aug-18 | Market Purchase | 13,500 | $2.01 | $27,110.70 | 6% 211.41K to 224.91K | 50% |
| 06-Aug-18 2:37 PM View: | Diaz-Mitoma Francisco Chief Medical Officer | Vbi Vaccines Inc/bc (VBIV) | 02-Aug-18 | Market Purchase | 3,000 | $2.20 | $6,600.00 | 1% 296.74K to 299.74K | 37% |
| 01-Aug-18 1:39 PM View: | Baxter Jeff CEO, President Director | Vbi Vaccines Inc/bc (VBIV) | 31-Jul-18 | Market Purchase | 16,800 | $2.28 | $38,236.80 | 9% 194.6K to 211.41K | 32% |
| 25-Jun-18 9:23 PM View: | Gillis Steven Director | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-18 | Option Exercise | 18,750 | -- | -- | < 1% 3.07M to 3.09M | |
| 18-Jun-18 10:52 AM View: | Rubin Steven D Director | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-18 | Option Exercise | 18,750 | -- | -- | 50% 37.5K to 56.25K | |
| 20-Jun-18 10:17 AM View: | Dewilde Michel Director | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-18 | Option Exercise | 12,500 | -- | -- | 50% 25.0K to 37.5K | |
| 18-Jun-18 10:49 AM View: | Logal Adam Director | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-18 | Option Exercise | 12,500 | -- | -- | 50% 25.0K to 37.5K | |
| 18-Jun-18 10:47 AM View: | Anderson David Evander Chief Scientific Officer | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-18 | Option Exercise | 21,875 | -- | -- | 25% 88.74K to 110.61K | |
| 18-Jun-18 10:51 AM View: | Requadt Scott Director | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-18 | Option Exercise | 12,500 | -- | -- | 50% 25.0K to 37.5K | |
| 18-Jun-18 10:45 AM View: | Beattie Nell Chief Business Officer | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-18 | Option Exercise | 6,250 | -- | -- | 50% 12.5K to 18.75K | |
| 18-Jun-18 10:44 AM View: | Baxter Jeff CEO, President Director | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-18 | Option Exercise | 31,250 | -- | -- | 19% 163.35K to 194.6K | |
| 18-Jun-18 10:47 AM View: | Anderson David Evander Chief Scientific Officer | Vbi Vaccines Inc/bc (VBIV) | 14-Jun-18 | Payment of Exercise | 9,306 | $3.76 | $34,990.60 | (8%) 110.61K to 101.31K | 20% |
| 25-May-18 1:54 PM View: | Baxter Jeff CEO, President Director | Vbi Vaccines Inc/bc (VBIV) | 24-May-18 | Market Purchase | 11,000 | $2.99 | $32,890.00 | 7% 152.35K to 163.35K | < 1% |
